192 related articles for article (PubMed ID: 12517677)
1. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
[TBL] [Abstract][Full Text] [Related]
2. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
[TBL] [Abstract][Full Text] [Related]
3. Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Felmeden DC; Spencer CG; Blann AD; Beevers DG; Lip GY
J Intern Med; 2003 Jan; 253(1):81-91. PubMed ID: 12588540
[TBL] [Abstract][Full Text] [Related]
4. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
5. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
Lip PL; Blann AD; Hope-Ross M; Gibson JM; Lip GY
Ophthalmology; 2001 Apr; 108(4):705-10. PubMed ID: 11297487
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung NA; Beevers DG; Lip G
Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
[TBL] [Abstract][Full Text] [Related]
7. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
Lip PL; Felmeden DC; Blann AD; Matheou N; Thakur S; Cunliffe IA; Lip GY
Br J Ophthalmol; 2002 Nov; 86(11):1299-302. PubMed ID: 12386093
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in myocardial infarction. An acute or chronic process?
Chung NA; Lydakis C; Belgore F; Blann AD; Lip GY
Eur Heart J; 2002 Oct; 23(20):1604-8. PubMed ID: 12323160
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.
Chung NA; Lydakis C; Belgore F; Li-Saw-Hee FL; Blann AD; Lip GY
Heart; 2003 Dec; 89(12):1411-5. PubMed ID: 14617549
[TBL] [Abstract][Full Text] [Related]
10. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
McGirt MJ; Lynch JR; Blessing R; Warner DS; Friedman AH; Laskowitz DT
Neurosurgery; 2002 Nov; 51(5):1128-34; discussion 1134-5. PubMed ID: 12383357
[TBL] [Abstract][Full Text] [Related]
11. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor.
Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
Gastric Cancer; 2002; 5(3):137-41. PubMed ID: 12378339
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
Makin AJ; Chung NA; Silverman SH; Lip GY
Clin Sci (Lond); 2003 Apr; 104(4):397-404. PubMed ID: 12653684
[TBL] [Abstract][Full Text] [Related]
13. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
[TBL] [Abstract][Full Text] [Related]
14. Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy.
Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
PLoS One; 2014; 9(7):e101779. PubMed ID: 25007257
[TBL] [Abstract][Full Text] [Related]
15. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Belgore FM; Blann AD; Lip GY
Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
[TBL] [Abstract][Full Text] [Related]
16. Angiogenin and hemoxygenase in pregnancy: influence of hypertension.
Karthikeyan VJ; Lip GY; Baghdadi S; Lane DA; Beevers DG; Blann AD
Angiology; 2012 Apr; 63(3):194-8. PubMed ID: 21602256
[TBL] [Abstract][Full Text] [Related]
17. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay.
Chung NA; Makin AJ; Lip GY
Eur J Clin Invest; 2003 Jul; 33(7):529-35. PubMed ID: 12814387
[TBL] [Abstract][Full Text] [Related]
18. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
Blann AD; Belgore FM; Constans J; Conri C; Lip GY
Am J Cardiol; 2001 May; 87(10):1160-3. PubMed ID: 11356390
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
Belgore FM; Lip GY; Blann AD
Br J Biomed Sci; 2000; 57(3):207-13. PubMed ID: 11050771
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
